risk sharing

Research in Review

Hypersensitivity Reactions Present Clinical, Economic Burden for Patients With NSCLC

03/24/2017

JCP Editors

Patients with non-small cell lung cancer (NSCLC) who develop hypersensitivity reactions to first-line chemotherapy are faced with increasing clinical burden and rising costs, according to research presented at the...

...

03/24/2017

Journal of Clinical Pathways

Department

Follow-up Guidelines Needed for Young Adult Cancer Survivors

03/15/2017

JCP Editors

Many young adult (YA) cancer survivors are unaware of potential long-term adverse effects of cancer therapies and of the necessity of follow-up care, according to a focus group of survivors aged between 18 and 39...

Many...

03/15/2017

Journal of Clinical Pathways

Research in Review

Link Shown Between Unsolicited Patient Complaints, Increased Postsurgical Complications

03/15/2017

JCP Editors

Patients receiving surgery from a surgeon with a high number of unsolicited patient observations may be at greater risk for postoperative complications, according to research published in JAMA Surgery (published...

...

03/15/2017

Journal of Clinical Pathways

Research in Review

Body Composition Impacts Chemo Toxicity for Patients With Breast Cancer

03/07/2017

JCP Editors

Using body composition metrics to determine dosage of anthracyclines-taxane based chemotherapy for patients with breast cancer can reduce treatment-related toxicity, according to a study published in Clinical Cancer...

Using...

03/07/2017

Journal of Clinical Pathways

Research in Review

Cetuximab Therapy for Anal Carcinoma Associated With Improved Outcomes, High Toxicity

03/03/2017

JCP Editors

Adding cetuximab to chemoradiation for squamous cell carcinoma of the anal canal is associated with lower incidence of locoregional failure but high toxicity, according to the results of a study published in the...

Adding...

03/03/2017

Journal of Clinical Pathways

Research in Review

Blood Condition Increases Risk of Adverse Events After ASCT for Patients With Lymphoma

02/13/2017

JCP Editors

Patients with an age-related blood condition undergoing autologous stem cell transplantation (ASCT) for lymphoma are at greater risk of adverse outcomes, reports a new study published in the Journal of Clinical...

...

02/13/2017

Journal of Clinical Pathways

Research in Review

Anxiety Increases Risk of Mortality for Patients With NSCLC

01/31/2017

JCP Editors

Patients with newly-diagnosed non-small cell lung cancer (NSCLC) who experience anxiety are at a higher risk of cancer-specific mortality, according to research published in the Journal of Pain and Symptom...

...

01/31/2017

Journal of Clinical Pathways

Research in Review

Blood Condition Increases Risk of Adverse Events After ASCT in Lymphoma

01/13/2017

JCP Editors

Patients with an age-related blood condition undergoing autologous stem-cell transplantation (ASCT) for lymphoma are at greater risk of adverse outcomes, says a new study published in the Journal of Clinical...

...

01/13/2017

Journal of Clinical Pathways

Research in Review

Prophylactic Treatment Reduces Toxicity in HER2+ Breast Cancer

01/11/2017

JCP Editors

Loperamide plus budesonide reduces the rate of toxic effects associated with neratinib for patients with human epidermal growth factor receptor-2 positive (HER2+) breast cancer, according to the results of a trial...

...

01/11/2017

Journal of Clinical Pathways

Perspectives

The Use of Risk-Sharing Agreements to Manage Costs, Mitigate Risk, and Improve Value for Pharmaceutical Products

10/28/2015

Alex Bastian, MBA

Deeksha Dua, MBBS, MPH

Sahand Mirzahossein, MBA

In this article, the authors review the types of RSAs that have been implemented to date, with a specific focus on two European countries (the United Kingdom and Italy) and on the United States.

In this article, the authors...

10/28/2015

Journal of Clinical Pathways